BETA3_LVH-206823 Functional website | ERD

Summary

A public website for the trial is implemented and functional

More information & hyperlinks

Web resources:

https://www.ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5a0cdd4e6&appId=PPGMS

Search

Associated projects

BETA3_LVH - A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease

Organisations

Not specified